Joann Hsu

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 427 citations · Full text

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Nicholas Salgia, Paulo Gustavo Bergerot, Manuel Caitano Maia et al. · European Urology · 2020 · 181 citations

Dysbiosis, Stool Microbiome Profiling, Cancer Immunosurveillance +6

Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis

Sunday S. Oladipupo, Craig Smith, Andrea Santeford et al. · Proceedings of the National Academy of Sciences · 2014 · 137 citations · Full text

Endothelial Cell Fgfr, Significance Fgf Receptor, Inflammation +20

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Rana R. McKay, Dominick Bossé, Wanling Xie et al. · Cancer Immunology Research · 2018 · 134 citations · Full text

The Multicopper Ferroxidase Hephaestin Enhances Intestinal Iron Absorption in Mice

Brie K. Fuqua, Yan Lu, Deepak Darshan et al. · PLoS ONE · 2014 · 85 citations · Full text

Nutrition, Iron Metabolism, Immunology +21